AFRM vs FENC · P/E 590, rev $4.26B vs rev $17.9M
Affirm Holdings Inc (AFRM) versus Fennec Pharmaceuticals Inc (FENC) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2026-06-30 was $4.26B. Net income was $1.93B. Revenue was up 32.2% from 2025-06-30 to 2026-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. FENC currently screens at market cap $302.2M.
Not investment advice. Open the AFRM and FENC stock pages for the full models.
Not investment advice.